Short Description Covalent Bioscience focuses on amyloid‑clearing antibodies to promote healthy aging.
Description Covalent Bioscience is a biotechnology company advancing research and development in the field of amyloid‑clearing antibodies. The organization combines scientific rigor with innovative technology to translate discoveries in immunosenescence into real‑world interventions aimed at extending both lifespan and healthspan. By targeting fundamental mechanisms of aging, Covalent Bioscience aims to deliver impactful solutions that help individuals live longer, healthier lives.